The hypertensive patient with multiple risk factors: Is treatment really so difficult?

American Journal of Hypertension

Volumn 10, Issue 10 II SUPPL., 1997, Pages

  Zanchetti, Alberto ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Fosinopril; Hydrochlorothiazide; Hypercholesterolemia; Hypertension; Pravastatin

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FOSINOPRIL; HYDROCHLOROTHIAZIDE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; B SCAN; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK MANAGEMENT; TREATMENT PLANNING;

EID: 0030726977     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(97)00327-0     Document Type: Article

References (20)

1. Zanchetti A. Hyperlipidemia in the hypertensive patient. Am J Med. 96(suppl 4A):1994;1S-6S.
2. Goode GK, Miller JP, Heagerty AM. Hyperlipidaemia, hypertension and coronary heart disease. Lancet. 345:1995;362-364.
3. Laurenzi M, Mancini M, Menotti A, et al. Multiple risk factors in hypertension results from the Gubbio Study . J Hypertens. 8(suppl 1):1990;S7-S12.
4. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia the key feature of a cardiovascular and metabolic syndrome . Diabetologia. 34:1991;416-422.
5. Zanchetti A, Chalmers J, Arakawa K, et al. 1993 Guidelines for the management of mild hypertension memorandum from a World Health Organization/International Society of Hypertension meeting . J Hypertens. 11:1993;905-918.
6. Pyörälä K, DeBacker G, Graham I, et al. Prevention of coronary heart disease in clinical practice recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension . Eur Heart J. 15:1994;1300-1331.
7. Multiple Risk Factor Intervention Trial risk factor changes and mortality results . JAMA. 248:1982;1465-1477.
8. Zanchetti A. Goals of antihypertensive treatment prevention of cardiovascular events and prevention of organ damage . Blood Press. 1:1992;205-211.
9. Zanchetti A. Presidential lecture Antihypertensive therapy: pride and prejudice . J Hypertens. 13:1995;1522-1528.
10. Zanchetti A. The antiatherogenic effects of antihypertensive drugs experimental and clinical evidence . Clin Exp Hypertens. A14:1992;307-331.
11. Zanchetti A. Antiatherosclerotic effects of calcium antagonists methodological problems for their assessment . High Blood Press. 3:1994;339-349.
12. Chobanian AV, Haudenschild CC, Nickerson C, Drago R. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension. 15:1990;327-331.
13. Chobanian AV, Haudenschild CC, Nickerson C, Hope S. Trandolapril inhibits atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Hypertension. 20:1992;473-477.
14. Kowala MC, Grove RI, Aberg G. Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids . Atherosclerosis. 108:1994;61-72.
15. Kowala MC, Recce R, Beyer S, Aberg G. Regression of early atherosclerosis in hyperlipidemic hamsters induced by fosinopril and captopril. J Cardiovasc Pharmacol. 25:1995;179-186.
16. Zanchetti A. Antiatherosclerotic effects of antihypertensive drugs recent evidence and ongoing trials . Clin Exp Hypertens. 18:1996;489-499.
17. Bond MG, Wilmoth SK, Enevold GL, Strickland HL. Detection and monitoring of asymptomatic atherosclerosis in clinical trials. Am J Med. 86(suppl 4A):1989;33-36.
18. Borhani N, Mercuri M, Borhani P, et al. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS) A randomized blood pressure trial . JAMA. 276:1996;785-791.
19. Hansson L, Zanchetti A. The antiatherosclerotic effect of calcium antagonists in man what did MIDAS actually show? Blood Press. 4:1995;133-136.
20. Plaque Hypertension Lipid-Lowering Italian Study a protocol for non-invasive evaluation of carotid atherosclerosis in hypercholesterolemic hypertensive subjects . J Hypertens. 11(suppl 5):1993;S314-S315.